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Although the greater predictive value of systolic (S) than diastolic (D) blood pressure (BP) was demonstrated 40 years ago, 1 studies on cardiovascular morbidity and mortality in subjects with hypertension have focused exclusively on systolic-diastolic hypertension, and DBP has been used as the exclusive criterion for the definition of the diseases. 2 Recently, this approach was changed, for two reasons. First, the SHEP study 3 showed that, under drug treatment, cardiovascular risk was significantly lowered in isolated systolic hypertension (ISH), a variety of hypertension involving the major absolute risk but associating elevated SBP with normal or low DBP. Second, pulse pressure (PP), which combines high SBP and low DBP in the elderly, has been recognised as an independent cardiovascular risk factor, particularly for myocardial infarction. 4, 5 As a consequence, for many years few studies have been conducted on the mechanisms of ISH in the elderly. Herein are presented three major hypotheses, which take into consideration: (i) the role of endothelium as a triggering factor in ISH development, (ii) the role of genetic factors, and (iii) the therapeutic approach to the disease.
Pathophysiological hypothesis: role of endothelium
Modern interpretations of the BP curve indicate that it can be divided into two components: a steady component mean arterial pressure, and a pulsatile component, PP. 6 While mean arterial pressure is governed by cardiac output and vascular resistance, implying a reduced calibre of small arteries in hypertension (or a reduced number of vessels), increased PP depends upon three independent haemodynamic mechanisms: pattern of ventricular ejection, rigidity of the aortic wall, and the timing of reflected waves, pointing to the role of large cularly in the fields of pathophysiology, aetiology and drug treatment. In this article, several hypotheses are presented on this subject arteries in high BP. Since ventricular ejection is normal or reduced in the elderly, and since mean arterial pressure is normal or only slightly increased in ISH subjects, increased rigidity of the arterial wall is thought to be responsible for the increased PP. 6 Classically, this increased rigidity is attributed to the presence of structural abnormalities of the aortic wall, involving calcifications, specific alterations and fragmentation of elastic tissue, and finally increased amounts of stiff wall material like collagen. 6 Besides the elderly population, ISH is frequently observed in subjects with end-stage renal disease undergoing haemodialysis. 7 In these patients, both increased shear and wall stress are present and contribute to the structural remodelling of the arterial wall, leading to reduced elasticity of the vessels independent of BP. In addition to altered mechanical factors, endothelium function is blunted, as shown by the response of forearm vessels to acetylcholine and the effect of nitrite oxide (NO) synthase inhibitors. 8 Furthermore, the presence of a specific inhibitor of constitutive NO production and/or release has been demonstrated in the bloodstream. 9 Finally, the loss of endothelial function is associated with a substantial hypertrophy of carotid arteries, suggesting that NO inhibition might be a factor initiating the development of arterial abnormalities via two different pathways. 10, 11 First, the absence of NO donors, which are vasoactive compounds able to increase arterial diameter and elasticity, 6, 12 contributes functionally to increased arterial rigidity. Second, the disappearance of the antihypertrophic effect of NO might explain the modified phenotype of smooth muscle cells, and favour extension of structural changes and the alterations of arterial mechanical properties. 10 On the basis of the following reasons, we hypothesise that similar mechanisms might operate in the large arteries of ISH subjects. First, in these subjects, endothelium function is altered by both age and hypertension, 13, 14 involving mainly a dampening of NO production and/or release. Second, in both acute and long-term situations, 6, 15, 16 NO donors, such as nitrates or derivatives, are able to increase arterial compliance and distensibility, and reduce systolic hypertension without decreasing DBP. This haemodynamic pattern is observed in old, but not young, ISH subjects. 16 Finally, in hypertension of the middle aged, a negative association has been observed between the reduced acetylcholine response of the forearm vessels and the increased wall thickness of the common carotid artery. 17 
An aetiological hypothesis: role of environmental and genetic factors
Increased sodium sensitivity is a classical feature in both old ISH subjects and spontaneously hypertensive rats (SHR). 18 In these animals, high sodium intake is associated with increased thickness of the large artery walls and accumulation of connective tissue, a pattern not observed in normotensive controls. 19, 20 With the exception of Dahl sodiumsensitive hypertensive rats, this process is not accompanied by a marked increase of BP, particularly in stroke-prone SHR. 21 In this latter strain, lowering sodium intake or administering diuretics reverses the structural and functional arterial alterations independently of BP, but in association with the disappearance of strokes. 18, 19 The same regression of vascular damage under low salt diet or diuretics is observed in stroke-prone-resistant SHR, in which aortic collagen diminishes markedly under spironolactone. 20, 22 Interestingly, in SHRs, sodium overload is associated with alterations of shear stress and endothelial function, 23 a situation in which the responses to a number of vasoactive compounds are blunted. On the other hand, the saltinduced arterial changes observed are seen only in the presence of a major genetic predisposition.
Genetic factors interacting with sodium and its regulatory mechanisms (like the renin-angiotensin system) might be involved in the pathophysiology of arterial stiffening. In a subpopulation of hypertensive subjects, angiotensin II type I receptor gene polymorphism was detected and found to be significantly associated with a pressure-independent elevation of pulse wave velocity (PWV), a classical marker of arterial stiffness. 24 This polymorphism is much more prevalent in older than younger subjects. 24 In SHR, collagen accumulation within the aortic wall, the major structural component of arterial stiffness, was shown to be selectively lower after blockade of AT 1 receptors, independently of BP and blockade of bradykinin receptors. 25 Increasing sodium intake attenuates the collagen changes induced by AT 1 receptors. 26 Finally, when converting-enzyme inhibitors are used, PWV is selectively decreased in the subgroup of subjects with the angiotensin II type 1 receptor gene polymorphism, whereas a comparable finding is not observed following administration of calcium-entry blockers. 27 Finally, our working hypothesis is that, in the hypertensive population, environmental (sodium) and genetic (renin-angiotensin system?) factors acting specifically on the aortic wall modulate the ageassociated increase of arterial stiffness and PP, a haemodynamic pattern which varies markedly from one subject to another. Many genes might be taken into consideration, such as those involved with aldosynthase, 28 NO-dependent endothelial function 29 or development of extracellular matrix.
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Treatment hypothesis: drug approach to ISH Over the past decade, both increased PP and increased stiffness of large artery wall materials have been recognised as independent cardiovascular risk factors in the elderly, primarily for myocardial infarction, and to a lesser extent, for stroke. 4, 5, [30] [31] [32] It remains to be determined whether decreasing PP or decreasing stiffness of wall materials or both might be the major goal of ISH treatment in the elderly.
Some studies have shown that nitrates, by slowing PWV and modifying wave reflections, are able to selectively lower SBP and PP without altering DBP, 6, 16, 33 but the consequences of this treatment on cardiovascular morbidity and mortality have not yet been already reported. On the other hand, in ISH, chronic thiazide diuretics and calcium-entry blockers 3, 34 are known to decrease cardiovascular morbidity and mortality by lowering SBP and PP. However, at the same time, DBP is also lowered, a process which tends to maintain an elevated PP, thus favouring myocardial ischaemia and infarction. Therefore, to treat ISH, more appropriate doses of conventional antihypertensive drugs like diuretics or calcium entry blockers should be tested. The development of new NO donors derived from endothelium is also an adequate goal.
Because nitrates reduce ISH even acutely, 15, 16 ie, without altering the arterial wall structure, another important objective for drug treatment might be to selectively decrease SBP over the long term by modifying the arterial wall structure, namely reducing the thickness, changing the composition of the wall material, or acting through a combination of both. Reversing wall thickness alone is not a major goal because this parameter is related to cardiovascular risk only for some hypertensive vessels, such as the common carotid artery, but not for others, for example the radial artery. Indeed, increased wall material stiffness, a newly described major cardiovascular risk factor, 30 is probably the key target of treatment which requires the restoration of a normal vessel-wall composition. In this way, three conventional approaches should be thoroughly evaluated: reduction of sodium intake and/or the administration of diuretics 21 ; blockade of the AT 1 receptors 25 ; and hormonal replacement therapy after menopause. 35 In addition, innovative drugs, particularly those acting directly or indirectly on elastin and/or collagen, 36 should be developed to address these potential targets of ISH.
